Sanofi investigated over epilepsy drug linked to birth defects

Sanofi investigated over epilepsy drug linked to birth defects

Source: 
Reuters
snippet: 

French drugmaker Sanofi (SASY.PA) said on Tuesday it was being investigated over Depakine, an epilepsy drug which caused birth malfunctions and slow neurological development when taken during pregnancy.